| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16.5M | -10.3% | +4.5% |
| Cost of Revenue | $14.0M | -16.7% | +8.1% |
| Gross Profit | $2.5M | +56.3% | -11.6% |
| R&D Expense | $2.1M | +0.7% | -19.8% |
| SG&A Expense | $6.5M | +9.3% | -27.4% |
| Operating Income | -$7.0M | +1.2% | +27.8% |
| Pre-tax Income | $2.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.1M | +60.1% | +66.8% |
| Accounts Receivable | $15.4M | -15.0% | -57.8% |
| Inventory | $25.2M | -18.7% | -40.5% |
| Current Assets | $62.5M | -6.2% | -35.9% |
| Total Assets | $73.8M | -8.1% | -38.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.0M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $43K | — | — |
| Financing Cash Flow | $61K | — | — |
| Free Cash Flow | $3.0M | — | — |
| +128.3% |
| +120.2% |
| Income Tax | -$2K | -115.4% | -150.0% |
| Net Income | $2.1M | +128.3% | +120.2% |
| EPS (Basic) | $0.22 | +124.2% | +116.7% |
| EPS (Diluted) | $0.22 | +124.2% | +116.7% |
| $26.0M |
| -13.7% |
| -48.3% |
| Total Liabilities | $42.8M | -31.1% | -38.6% |
| Stockholders' Equity | $31.1M | +69.5% | -38.9% |